Komori
Daishin Chemical (4629) · RiskRestated

Accounting estimates and uncertainty surrounding assumptions

First written in FY2021. 8 of 9 entries say "Restated". Latest entry: FY2024.

9entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20242021: 320212022: 320222023: 220232024: 12024
Same theme, other companies
Risk of Financial-Statement Fluctuations Associated with Multiple Accounting Estimates and ValuationsA theme 35 companies write about · 34 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 4 of 21 companies on the "Worse" side.

19 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 35 companies compared. The sentences above are computed from all 35.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「In preparing these consolidated financial statements, we use estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. The amounts based on these estimates and assumptions may differ from actual results.」

    The company has continued to disclose the possibility that changes in estimates relating to the allowance for doubtful accounts, deferred tax assets, retirement benefit obligations and impairment of fixed assets could affect the financial statements.
  2. FY2024-Q2RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year regarding accounting estimates related to the impact of COVID-19, including assumptions regarding when it will subside.」

    The company has reconfirmed that there have been no material changes to the assumptions underlying the accounting estimates regarding the timing of the containment of COVID-19 and other matters.
  3. FY2023-Q3RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year regarding the impact of the COVID-19 pandemic, including assumptions regarding how it will spread in the future and when it will subside.」

    The company has reconfirmed that there have been no material changes to the accounting assumptions regarding the future spread of COVID-19 and the timing of its subsiding.
  4. FY2023-Q2RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year regarding the impact of the COVID-19 pandemic, including assumptions regarding how it will spread in the future and when it will subside.」

    The company has reconfirmed that there have been no material changes to the accounting assumptions regarding the future spread of COVID-19 and the timing of its subsiding.
  5. FY2023-Q1RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year regarding the impact of the COVID-19 pandemic, including assumptions regarding how it will spread in the future and when it will subside.」

    The company has reconfirmed that there have been no material changes to the accounting assumptions regarding the future spread of COVID-19 and the timing of its subsiding.
  6. FY2022-Q3RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year, including assumptions regarding how the COVID-19 pandemic will spread in the future and when it will subside.」

    The company has reconfirmed that there have been no material changes to the accounting assumptions regarding the future spread of COVID-19 and the timing of its subsiding.
  7. FY2022-Q2RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year, including assumptions regarding how the COVID-19 pandemic will spread in the future and when it will subside.」

    The company has reconfirmed that there have been no material changes to the accounting assumptions regarding the future spread of COVID-19 and the timing of its subsiding.
  8. FY2022-Q1RestatedAnnual report

    「There have been no material changes to the assumptions described in the additional information section of the securities report for the previous fiscal year, including assumptions regarding how the COVID-19 pandemic will spread in the future and when it will subside.」

    The company has reconfirmed that there have been no material changes to the accounting assumptions regarding the future spread of COVID-19 and the timing of its subsiding.
  9. FY2021First statedAnnual report

    「If these estimates and assumptions need to be revised due to changes in uncertain future economic conditions or other factors, the revisions could have a material impact on the amounts of deferred tax assets and income taxes—deferred recognized in the financial statements for the following fiscal year and thereafter.」

    The company has disclosed for the first time as a separate item that changes in estimates arising from future economic conditions and other factors could have a material impact on the financial statements with respect to the allowance for doubtful accounts, deferred tax assets, retirement benefit obligations and impairment of fixed assets.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daishin Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Accounting estimates and uncertainty surrounding assumptions | DAISHIN CHEMICAL CO.,LTD. (4629) | Komori